Jason A. Sprowl

1.9k total citations
34 papers, 1.2k citations indexed

About

Jason A. Sprowl is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, Jason A. Sprowl has authored 34 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 11 papers in Pediatrics, Perinatology and Child Health and 7 papers in Pharmacology. Recurrent topics in Jason A. Sprowl's work include Drug Transport and Resistance Mechanisms (23 papers), Pharmacological Effects and Toxicity Studies (10 papers) and Pharmacogenetics and Drug Metabolism (7 papers). Jason A. Sprowl is often cited by papers focused on Drug Transport and Resistance Mechanisms (23 papers), Pharmacological Effects and Toxicity Studies (10 papers) and Pharmacogenetics and Drug Metabolism (7 papers). Jason A. Sprowl collaborates with scholars based in United States, Netherlands and Canada. Jason A. Sprowl's co-authors include Alex Sparreboom, Alice A. Gibson, Giuliano Ciarimboli, Cynthia S. Lancaster, Amadeo M. Parissenti, Shuiying Hu, Ron H.J. Mathijssen, Eberhard Schlatter, Laura J. Janke and Baoqing Guo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and Clinical Cancer Research.

In The Last Decade

Jason A. Sprowl

31 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jason A. Sprowl United States 19 747 315 295 188 151 34 1.2k
Alice A. Gibson United States 23 790 1.1× 391 1.2× 261 0.9× 180 1.0× 213 1.4× 46 1.4k
Run Lu United States 18 636 0.9× 470 1.5× 232 0.8× 124 0.7× 121 0.8× 26 1.5k
Cynthia S. Lancaster United States 13 459 0.6× 226 0.7× 206 0.7× 116 0.6× 90 0.6× 16 792
Kouichi Kurose Japan 22 489 0.7× 661 2.1× 238 0.8× 352 1.9× 456 3.0× 54 2.0k
Hideharu Domoto Japan 10 582 0.8× 556 1.8× 128 0.4× 398 2.1× 184 1.2× 28 1.7k
Jun-ichi Sawada Japan 20 751 1.0× 696 2.2× 258 0.9× 49 0.3× 243 1.6× 42 1.4k
Jason R. Manro United States 14 556 0.7× 420 1.3× 244 0.8× 86 0.5× 323 2.1× 28 1.3k
Jochen Zisowsky Switzerland 9 341 0.5× 286 0.9× 165 0.6× 219 1.2× 28 0.2× 17 789
Tohru Onogawa Japan 17 661 0.9× 329 1.0× 222 0.8× 27 0.1× 89 0.6× 28 1.1k
Christelle Cauffiez France 23 239 0.3× 720 2.3× 174 0.6× 99 0.5× 295 2.0× 60 1.5k

Countries citing papers authored by Jason A. Sprowl

Since Specialization
Citations

This map shows the geographic impact of Jason A. Sprowl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason A. Sprowl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason A. Sprowl more than expected).

Fields of papers citing papers by Jason A. Sprowl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason A. Sprowl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason A. Sprowl. The network helps show where Jason A. Sprowl may publish in the future.

Co-authorship network of co-authors of Jason A. Sprowl

This figure shows the co-authorship network connecting the top 25 collaborators of Jason A. Sprowl. A scholar is included among the top collaborators of Jason A. Sprowl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason A. Sprowl. Jason A. Sprowl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nepal, Mahesh R., Eman Ahmed, Yue Xu, et al.. (2025). Regulation of hepatic organic anion transporting polypeptide 1B-type transport function by the protein kinase LYN. Drug Metabolism and Disposition. 53(9). 100138–100138.
2.
Hafey, Michael J., Lauren M. Aleksunes, Christy C. Bridges, et al.. (2022). Transporters and Toxicity: Insights From the International Transporter Consortium Workshop 4. Clinical Pharmacology & Therapeutics. 112(3). 527–539. 7 indexed citations
3.
Chen, Mingqing, Alice A. Gibson, Shichen Shen, et al.. (2021). Regulation of OATP1B1 Function by Tyrosine Kinase–mediated Phosphorylation. Clinical Cancer Research. 27(15). 4301–4310. 27 indexed citations
4.
Sprowl, Jason A., et al.. (2021). Current Understanding of Membrane Transporters as Regulators or Targets for Cisplatin-Induced Hearing Loss. Molecular Pharmacology. 100(4). 348–355. 5 indexed citations
5.
Huang, Kevin M., Alix F. Leblanc, Paola Alberti, et al.. (2020). Differential Contribution of Neuronal Uptake Transporters to Oxaliplatin Peripheral Neurotoxicity. The FASEB Journal. 34(S1). 1–1. 2 indexed citations
6.
Evers, Raymond, Micheline Piquette‐Miller, Joseph W. Polli, et al.. (2018). Disease‐Associated Changes in Drug Transporters May Impact the Pharmacokinetics and/or Toxicity of Drugs: A White Paper From the International Transporter Consortium. Clinical Pharmacology & Therapeutics. 104(5). 900–915. 96 indexed citations
7.
Hu, Shuiying, Jason A. Sprowl, Eberhard Schlatter, et al.. (2017). Identification of OAT1/OAT3 as Contributors to Cisplatin Toxicity. Clinical and Translational Science. 10(5). 412–420. 40 indexed citations
8.
Lanvers‐Kaminsky, Claudia, Jason A. Sprowl, Dirk Deuster, et al.. (2015). Human OCT2 Variant C.808G>T Confers Protection Effect Against Cisplatin-Induced Ototoxicity. Pharmacogenomics. 16(4). 323–332. 55 indexed citations
9.
Pabla, Navjotsingh, Alice A. Gibson, Michael J. Buege, et al.. (2015). Mitigation of acute kidney injury by cell-cycle inhibitors that suppress both CDK4/6 and OCT2 functions. Proceedings of the National Academy of Sciences. 112(16). 5231–5236. 81 indexed citations
10.
Sprowl, Jason A., Cynthia S. Lancaster, Navjotsingh Pabla, et al.. (2014). Cisplatin-Induced Renal Injury Is Independently Mediated by OCT2 and p53. Clinical Cancer Research. 20(15). 4026–4035. 61 indexed citations
11.
Graan, Anne‐Joy M. de, Laure Elens, Jason A. Sprowl, et al.. (2013). CYP3A4*22 Genotype and Systemic Exposure Affect Paclitaxel-Induced Neurotoxicity. Clinical Cancer Research. 19(12). 3316–3324. 91 indexed citations
12.
Sprowl, Jason A. & Alex Sparreboom. (2013). Uptake Carriers and Oncology Drug Safety. Drug Metabolism and Disposition. 42(4). 611–622. 28 indexed citations
13.
Sprowl, Jason A., Vanesa Gregorc, Chiara Lazzari, et al.. (2012). Associations Between ABCC2 Polymorphisms and Cisplatin Disposition and Efficacy. Clinical Pharmacology & Therapeutics. 91(6). 1022–1026. 29 indexed citations
14.
Ciarimboli, Giuliano, Cynthia S. Lancaster, Eberhard Schlatter, et al.. (2012). Proximal Tubular Secretion of Creatinine by Organic Cation Transporter OCT2 in Cancer Patients. Clinical Cancer Research. 18(4). 1101–1108. 125 indexed citations
15.
Sprowl, Jason A., Torben Stamm Mikkelsen, Hugh Giovinazzo, & Alex Sparreboom. (2012). Contribution of tumoral and host solute carriers to clinical drug response. Drug Resistance Updates. 15(1-2). 5–20. 24 indexed citations
16.
Sprowl, Jason A., Rachel A. Ness, & Alex Sparreboom. (2012). Polymorphic Transporters and Platinum Pharmacodynamics. Drug Metabolism and Pharmacokinetics. 28(1). 19–27. 50 indexed citations
17.
Sprowl, Jason A., et al.. (2012). 146 Identification of Tyrosine Kinase Inhibitors as Modulators of OCT2 Function. European Journal of Cancer. 48. 45–45. 1 indexed citations
19.
Sprowl, Jason A., Stephen Armstrong, Carita Lannér, et al.. (2012). Alterations in tumor necrosis factor signaling pathways are associated with cytotoxicity and resistance to taxanes: a study in isogenic resistant tumor cells. Breast Cancer Research. 14(1). R2–R2. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026